U
Nirvana Life Sciences Inc. NIRVF
$0.0083 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Rating U
Reward Index Unrated
Risk Index Unrated
Risk Grade U
Reward Grade U
Rating Factors NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index Unrated
Growth Index Unrated
Efficiency Index Unrated
Solvency Index Unrated
Total Return Index Unrated
Volatility Index Unrated
Beta / Standard Deviation NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Beta --
Price History NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 0.40%
30-Day Total Return 0.40%
60-Day Total Return --
90-Day Total Return --
Year to Date Total Return 0.40%
1-Year Total Return --
2-Year Total Return --
3-Year Total Return --
5-Year Total Return --
52-Week High % Change 0.00%
52-Week Low % Change 0.00%
Price NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.01
52-Week Low Price $0.01
52-Week Low Price (Date) Jan 30, 2025
52-Week High Price (Date) Jan 30, 2025
Valuation NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 167.34K
Enterprise Value 230.33K
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.01
Earnings Per Share Growth -76.53%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) -0.45
Enterprise Value/Revenue (TTM) --
Price $0.01
Enterprise Value/EBITDA (TTM) -5.31
Enterprise Value/EBIT -5.09
Market Cap Category Nano Cap
Dividends and Shares NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 48.23M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 604-401-8100
Address 650 West Georgia Street Vancouver, BC V6B 4N8
Website nirvanalifescience.com
Country Canada
Year Founded --
Profitability NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -227.91%
Return on Equity --
Income Statement NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -323.20K
EBIT (TTM) -337.30K
Net Income (TTM) -338.00K
Net Income Avl. to Common (TTM) -338.00K
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 63.88%
EPS Diluted (TTM) -0.01
EPS Diluted Growth (Q YOY) 65.38%
Balance Sheet NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 400.00
Cash Per Share (Q) $0.00
Total Current Assets (Q) 14.00K
Total Preferred Equity (Q) --
Total Equity (Q) -890.80K
Current Ratio (Q) 0.015
Book Value Per Share (Q) -$0.02
Total Assets (Q) 140.50K
Total Current Liabilities (Q) 906.30K
Total Debt (Q) 49.60K
Total Liabilities (Q) 1.03M
Total Common Equity (Q) -886.90K
Cash Flow NIRVF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 36.30K
Net Change in Cash (TTM) -7.40K
Levered Free Cash Flow (TTM) 92.20K
Cash from Operations (TTM) -32.40K
Weiss Ratings